USE OF DERMATAN SULPHATE FOR THE PREVENTION AND THERAPY OF CEREBRAL AGING AND OF CENTRAL NERVOUS SYSTEM FUNCTIONAL DEFICIT STATES

摘要

The present invention refers to the use of Dermatan sulphate, in its natural form and in its low molecular weight form, possibly in association with heparin, for the preparation of pharmaceutical compositions to be administered per os and parenterally in the preventive and therapeutic treatment of cerebral aging, of demential infantile and senile forms, of syndroms correlated to an altered biochemistry of the glycosaminoglycane sulphates, of hypofunctionality and dismetabolism of the central nervous system following an excessive use of drugs and to toxicodependency.